|
|
|
|
| LEADER |
00659Cmm#a2200229#a#4500 |
| 001 |
OMD008430 |
| 003 |
OMD |
| 005 |
20141117103818 |
| 008 |
060829t2001||||xxu| ||| |||||||eng d |
| 040 |
# |
# |
|a OMD
|b spa
|
| 060 |
# |
4 |
|a WP
|b 870
|
| 092 |
# |
# |
|c WP 870
|l HER
|
| 245 |
0 |
# |
|a Herceptin :
|b a strong foundation for hes2-driven metastic breast cancer /
|c Genentech.
|
| 260 |
# |
# |
|a San Francisco :
|b Genentech,
|c c2001.
|
| 300 |
# |
# |
|a 1 CD-ROM
|
| 650 |
# |
7 |
|a Neoplasias de la mama
|2 Decs
|
| 650 |
# |
7 |
|a CD-ROM
|2 Decs
|
| 653 |
# |
# |
|a Cancer de la mama
|
| 710 |
# |
# |
|a Genentech.
|
| 866 |
# |
0 |
|a 1 ej.
|
| 952 |
# |
# |
|w 060829
|p OMDCD126
|t ej.1
|a OMD
|b OMD
|o WP 870 HER [SALA]
|7 1
|y CDR
|
| 999 |
# |
# |
|a Sandra
|
